Artigos de revistas sobre o tema "Generation of negative triples"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Generation of negative triples".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Vallée-Tourangeau, Frédéric, Neville G. Austin e Sandra Rankin. "Inducing a Rule in Wason's 2–4–6 Task: A Test of the Information-Quantity and Goal-Complementarity Hypotheses". Quarterly Journal of Experimental Psychology Section A 48, n.º 4 (novembro de 1995): 895–914. http://dx.doi.org/10.1080/14640749508401422.
Texto completo da fonteVallée-Tourangeau, Frédéric. "Utilities in the 2-4-6 Task". Experimental Psychology 59, n.º 5 (1 de maio de 2012): 265–71. http://dx.doi.org/10.1027/1618-3169/a000152.
Texto completo da fonteWang, Liuquan. "Arithmetic identities and congruences for partition triples with 3-cores". International Journal of Number Theory 12, n.º 04 (10 de abril de 2016): 995–1010. http://dx.doi.org/10.1142/s1793042116500627.
Texto completo da fonteTierno, Domenico, Gabriele Grassi, Serena Scomersi, Marina Bortul, Daniele Generali, Fabrizio Zanconati e Bruna Scaggiante. "Next-Generation Sequencing and Triple-Negative Breast Cancer: Insights and Applications". International Journal of Molecular Sciences 24, n.º 11 (2 de junho de 2023): 9688. http://dx.doi.org/10.3390/ijms24119688.
Texto completo da fonteWu, Jiande, Tarun K. K. Mamidi, Lu Zhang e Chindo Hicks. "Delineation of the Germline and Somatic Mutation Interaction Landscape in Triple-Negative and Non-Triple-Negative Breast Cancer". International Journal of Genomics 2020 (7 de julho de 2020): 1–16. http://dx.doi.org/10.1155/2020/2641370.
Texto completo da fonteLin, Po‐Han, Ming Chen, Li‐Wei Tsai, Chiao Lo, Tzu‐Chun Yen, Thomas Yoyan Huang, Chih‐Kai Chen, Sheng‐Chih Fan, Sung‐Hsin Kuo e Chiun‐Sheng Huang. "Using next‐generation sequencing to redefine BRCAness in triple‐negative breast cancer". Cancer Science 111, n.º 4 (19 de fevereiro de 2020): 1375–84. http://dx.doi.org/10.1111/cas.14313.
Texto completo da fonteWu, Jiande, Tarun Karthik Kumar Mamidi, Lu Zhang e Chindo Hicks. "Unraveling the Genomic-Epigenomic Interaction Landscape in Triple Negative and Non-Triple Negative Breast Cancer". Cancers 12, n.º 6 (12 de junho de 2020): 1559. http://dx.doi.org/10.3390/cancers12061559.
Texto completo da fonteRaftery, Martin J., Alexander Sebastian Franzén, Clarissa Radecke, Abdelhadi Boulifa, Günther Schönrich, Sebastian Stintzing, Jens-Uwe Blohmer e Gabriele Pecher. "Next Generation CD44v6-Specific CAR-NK Cells Effective against Triple Negative Breast Cancer". International Journal of Molecular Sciences 24, n.º 10 (20 de maio de 2023): 9038. http://dx.doi.org/10.3390/ijms24109038.
Texto completo da fonteZhang, Zhenghang, Jinlu Jia, Yalin Wan, Yang Zhou, Yuting Kong, Yurong Qian e Jun Long. "TransR*: Representation learning model by flexible translation and relation matrix projection". Journal of Intelligent & Fuzzy Systems 40, n.º 5 (22 de abril de 2021): 10251–59. http://dx.doi.org/10.3233/jifs-202177.
Texto completo da fonteBen-Baruch, Noa, Tamar Peretz-Yablonski, Georgeta Fried, Moshe J. Inbar, Yousef Samih, Victoria Neiman, Bella Nisenbaum et al. "Next-generation sequencing (NGS) in relapsed/refractory triple-negative breast cancer (TNBC) in Israel." Journal of Clinical Oncology 32, n.º 15_suppl (20 de maio de 2014): 1028. http://dx.doi.org/10.1200/jco.2014.32.15_suppl.1028.
Texto completo da fonteThouvenot, B., S. Verdun, J. Tomasina, B. Hilselberger, M. Brulliard, L. Bonnard, M. Trarbach, J. Armand, V. Ogier e B. E. Bihain. "P272 Using next-generation sequencing to predict clinical outcome of triple negative breast cancer". Breast 24 (março de 2015): S120. http://dx.doi.org/10.1016/s0960-9776(15)70304-8.
Texto completo da fonteElsayed, Islam, e Yoshiki Nishi. "A Feasibility Study on Power Generation from Solar Thermal Wind Tower: Inclusive Impact Assessment Concerning Environmental and Economic Costs". Energies 11, n.º 11 (16 de novembro de 2018): 3181. http://dx.doi.org/10.3390/en11113181.
Texto completo da fonteCaiazza, Francesco, Alyson Murray, Stephen F. Madden, Naoise C. Synnott, Elizabeth J. Ryan, Norma O’Donovan, John Crown e Michael J. Duffy. "Preclinical evaluation of the AR inhibitor enzalutamide in triple-negative breast cancer cells". Endocrine-Related Cancer 23, n.º 4 (abril de 2016): 323–34. http://dx.doi.org/10.1530/erc-16-0068.
Texto completo da fonteLips, Esther H., Magali Michaut, Lennart Mulder, Nicolle Besselink, Marlous L. Hoogstraat, Marco J. Koudijs, Emile E. Voest et al. "Next-generation sequencing to find predictors for chemotherapy response in triple-negative breast cancer (TNBC)." Journal of Clinical Oncology 31, n.º 15_suppl (20 de maio de 2013): 1010. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.1010.
Texto completo da fonteHu, Zhiwei, Rulong Shen, Amanda Campbell, Elizabeth McMichael, Lianbo Yu, Bhuvaneswari Ramaswamy, Cheryl A. London, Tian Xu e William E. Carson. "Targeting Tissue Factor for Immunotherapy of Triple-Negative Breast Cancer Using a Second-Generation ICON". Cancer Immunology Research 6, n.º 6 (5 de abril de 2018): 671–84. http://dx.doi.org/10.1158/2326-6066.cir-17-0343.
Texto completo da fonteWang, Wei, Hao Chen, Yang Xie, Sayantap Datta, Wei Li e Ruiwen Zhang. "Abstract 678: Experimental therapy of triple negative breast cancer with next-generation of MDM2 inhibitors". Cancer Research 84, n.º 6_Supplement (22 de março de 2024): 678. http://dx.doi.org/10.1158/1538-7445.am2024-678.
Texto completo da fonteDenu, Ryan A., Cissimol P. Joseph, Elizabeth S. Urquiola, Precious S. Byrd, Richard K. Yang, Ravin Ratan, Maria Alejandra Zarzour et al. "Utility of Clinical Next Generation Sequencing Tests in KIT/PDGFRA/SDH Wild-Type Gastrointestinal Stromal Tumors". Cancers 16, n.º 9 (27 de abril de 2024): 1707. http://dx.doi.org/10.3390/cancers16091707.
Texto completo da fonteKareev, Yaakov, Naftali Halberstadt e Dorit Shafir. "Improving Performance and Increasing the Use of Non-Positive Testing in a Rule-Discovery Task". Quarterly Journal of Experimental Psychology Section A 46, n.º 4 (novembro de 1993): 729–42. http://dx.doi.org/10.1080/14640749308401036.
Texto completo da fonteHossain, Fokhrul, Samarpan Majumder, Justin David e Lucio Miele. "Precision Medicine and Triple-Negative Breast Cancer: Current Landscape and Future Directions". Cancers 13, n.º 15 (26 de julho de 2021): 3739. http://dx.doi.org/10.3390/cancers13153739.
Texto completo da fonteAlewine, Christine, Laiman Xiang, Takao Yamori, Gerhard Niederfellner, Klaus Bosslet e Ira Pastan. "Efficacy of RG7787, a Next-Generation Mesothelin-Targeted Immunotoxin, against Triple-Negative Breast and Gastric Cancers". Molecular Cancer Therapeutics 13, n.º 11 (19 de setembro de 2014): 2653–61. http://dx.doi.org/10.1158/1535-7163.mct-14-0132.
Texto completo da fonteZhu, X., J. Bayani, M. Dewan, H. Tovey, L. Kilburn, K. Taylor, J. Banerji et al. "307P Identifying new biological subgroups of triple-negative breast cancer using next-generation integrative clustering pipeline". Annals of Oncology 34 (outubro de 2023): S306—S307. http://dx.doi.org/10.1016/j.annonc.2023.09.503.
Texto completo da fonteBhattarai, Shristi, Geetanjali Saini, Hongxiao Li, Gaurav Seth, Timothy B. Fisher, Emiel A. M. Janssen, Umay Kiraz, Jun Kong e Ritu Aneja. "Predicting Neoadjuvant Treatment Response in Triple-Negative Breast Cancer Using Machine Learning". Diagnostics 14, n.º 1 (28 de dezembro de 2023): 74. http://dx.doi.org/10.3390/diagnostics14010074.
Texto completo da fonteKhandelwal, Soni, Mallory Boylan, Gilbert Kirsch, Julian E. Spallholz e Lauren S. Gollahon. "Investigating the Potential of Conjugated Selenium Redox Folic Acid as a Treatment for Triple Negative Breast Cancer". Antioxidants 9, n.º 2 (5 de fevereiro de 2020): 138. http://dx.doi.org/10.3390/antiox9020138.
Texto completo da fontePircher, Magdalena, Thomas Winder e Andreas Trojan. "Response to Vemurafenib in Metastatic Triple-Negative Breast Cancer Harbouring a BRAF V600E Mutation: A Case Report and Electronically Captured Patient-Reported Outcome". Case Reports in Oncology 14, n.º 1 (29 de março de 2021): 616–21. http://dx.doi.org/10.1159/000513905.
Texto completo da fonteHerrera Juarez, Mercedes, Pablo Tolosa Ortega, Ana Sanchez de Torre e Eva Ciruelos Gil. "Biology of the Triple-Negative Breast Cancer: Immunohistochemical, RNA, and DNA Features". Breast Care 15, n.º 3 (2020): 208–16. http://dx.doi.org/10.1159/000508758.
Texto completo da fonteDesa, Danielle E., Wencheng Wu, Robert M. Brown, Edward B. Brown, Robert L. Hill, Bradley M. Turner e Edward B. Brown. "Second-Harmonic Generation Imaging Reveals Changes in Breast Tumor Collagen Induced by Neoadjuvant Chemotherapy". Cancers 14, n.º 4 (9 de fevereiro de 2022): 857. http://dx.doi.org/10.3390/cancers14040857.
Texto completo da fonteYang, Biyao, Rui Sang, Yi Li, Ewa Goldys e Wei Deng. "Abstract 5743: Liposome platform enables X-ray induced photodynamic therapy treatment against human triple negative breast cancer cells". Cancer Research 84, n.º 6_Supplement (22 de março de 2024): 5743. http://dx.doi.org/10.1158/1538-7445.am2024-5743.
Texto completo da fonteNagahashi, Masayuki, Tetsu Hayashida, Yuko Kitagawa, Manabu Futamura, Kazuhiro Yoshida, Takashi Kuwayama, Seigo Nakamura et al. "Comprehensive genomic sequencing for triple negative breast cancer in Japan." Journal of Clinical Oncology 35, n.º 15_suppl (20 de maio de 2017): e23122-e23122. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e23122.
Texto completo da fonteAshourpour, Maryam, Fatemeh Mostafavi Hosseini, Mohsen Amini, Ebrahim Saeedian Moghadam, Faranak Kazerouni, Seyed Yousef Arman e Zahra Shahsavari. "Pyrazole Derivatives Induce Apoptosis via ROS Generation in the Triple Negative Breast Cancer Cells, MDA-MB-468". Asian Pacific Journal of Cancer Prevention 22, n.º 7 (1 de julho de 2021): 2079–87. http://dx.doi.org/10.31557/apjcp.2021.22.7.2079.
Texto completo da fonteWeisman, Paul S., Charlotte K. Y. Ng, Edi Brogi, Rachel E. Eisenberg, Helen H. Won, Salvatore Piscuoglio, Maria R. De Filippo et al. "Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology". Modern Pathology 29, n.º 5 (4 de março de 2016): 476–88. http://dx.doi.org/10.1038/modpathol.2016.39.
Texto completo da fonteSangiorgio, Valentina, Rocco Giovanni Piazza, Federica Mottadelli, Fabio Pagni, Inzoli Elena, Carlo Gambacorti-Passerini, Gianni Cazzaniga e Elena Maria Elli. "P1056: NEXT GENERATION SEQUENCING IDENTIFIES SUBGROUPS OF PATIENTS WITH TRIPLE NEGATIVE/ PRIMARY THROMBOCYTOSIS WITH DIFFERENT CLINICAL OUTCOMES". HemaSphere 7 (agosto de 2023): e7820571. http://dx.doi.org/10.1097/01.hs9.0000971120.78205.71.
Texto completo da fonteBerisha, Eranda, Maria del Carmen Chacon Castro, Adnin Ashrafi, Narges Salamat, Parinaz Sadat Alemi e Li Zhang. "Abstract 4942: Heme targeting and its mechanistic role in triple-negative breast cancer suppression". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 4942. http://dx.doi.org/10.1158/1538-7445.am2023-4942.
Texto completo da fonteYun, Jiwon, Jung-Ah Kim, Byungjin Hwang, Hee Sue Park, Kyongok Im, Sung-Min Kim, Dajeong Jeong, Kyu Min Lim, Duhee Bang e Dong Soon Lee. "Triple-Negative Myeloproliferative Neoplasms Vs. Calr, JAK2 or MPL-Mutated Myeloproliferative Neoplasms: Distinct Molecular Characteristics". Blood 132, Supplement 1 (29 de novembro de 2018): 1772. http://dx.doi.org/10.1182/blood-2018-99-118013.
Texto completo da fonteMorris, Lindsay Kaye, Matthew Stein, Saradasri Karri, Srishti Sareen, Kruti Patel, Gregory A. Vidal, Lee Steven Schwartzberg e Michael Gary Martin. "Distribution of receptor tyrosine kinase (RTK) nsSNPs in breast cancer (BC) patients (pts) using next-generation sequencing (NGS)." Journal of Clinical Oncology 35, n.º 15_suppl (20 de maio de 2017): 1080. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.1080.
Texto completo da fonteKalyane, Dnyaneshwar, Suryanarayana Polaka, Nupur Vasdev e Rakesh Kumar Tekade. "CD44-Receptor Targeted Gold-Doxorubicin Nanocomposite for Pulsatile Chemo-Photothermal Therapy of Triple-Negative Breast Cancer Cells". Pharmaceutics 14, n.º 12 (6 de dezembro de 2022): 2734. http://dx.doi.org/10.3390/pharmaceutics14122734.
Texto completo da fonteSvidnicki, Maria Carolina Costa Melo, Paula De Melo Campos, Moisés Alves Ferreira Filho, Caio Augusto Leme Fujiura, Tetsuichi Yoshizato, Hideki Makishima, Seishi Ogawa e Sara T. Olalla Saad. "Mutations in Triple-Negative Patients with Myeloproliferative Neoplasms". Blood 134, Supplement_1 (13 de novembro de 2019): 5395. http://dx.doi.org/10.1182/blood-2019-128764.
Texto completo da fonteDameri, Martina, Lorenzo Ferrando, Gabriella Cirmena, Claudio Vernieri, Giancarlo Pruneri, Alberto Ballestrero e Gabriele Zoppoli. "Multi-Gene Testing Overview with a Clinical Perspective in Metastatic Triple-Negative Breast Cancer". International Journal of Molecular Sciences 22, n.º 13 (1 de julho de 2021): 7154. http://dx.doi.org/10.3390/ijms22137154.
Texto completo da fonteBahman, Fatemah, Valeria Pittalà, Mohamed Haider e Khaled Greish. "Enhanced Anticancer Activity of Nanoformulation of Dasatinib against Triple-Negative Breast Cancer". Journal of Personalized Medicine 11, n.º 6 (15 de junho de 2021): 559. http://dx.doi.org/10.3390/jpm11060559.
Texto completo da fonteHe, W., Y. Zhang, Y. Deng e D. Kabelitz. "Induction of TCR-gamma delta expression on triple-negative (CD3-4-8-) human thymocytes. Comparative analysis of the effects of IL-4 and IL-7." Journal of Immunology 154, n.º 8 (15 de abril de 1995): 3726–31. http://dx.doi.org/10.4049/jimmunol.154.8.3726.
Texto completo da fonteBian, Yanlin, Tong Lin, Tanja Jakos, Xiaodong Xiao e Jianwei Zhu. "The Generation of Dual-Targeting Fusion Protein PD-L1/CD47 for the Inhibition of Triple-Negative Breast Cancer". Biomedicines 10, n.º 8 (30 de julho de 2022): 1843. http://dx.doi.org/10.3390/biomedicines10081843.
Texto completo da fonteWang, Nan, Kun Li, Wenfa Huang, Weiyao Kong, Xiaoran Liu, Weijie Shi, Feng Xie et al. "Efficacy of platinum in advanced triple-negative breast cancer with germline BRCA mutation determined by next generation sequencing". Chinese Journal of Cancer Research 32, n.º 2 (2020): 149–62. http://dx.doi.org/10.21147/j.issn.1000-9604.2020.02.03.
Texto completo da fonteHuang, Xin, Huanwen M. Wu, Changbin Zhu, Di Shao, Dan Guo, Yidong Zhou, Yan Lin et al. "Next generation sequencing reveals CCNE1 amplification as an independent prognostic factor for triple negative breast cancer (TNBC) patients." Journal of Clinical Oncology 38, n.º 15_suppl (20 de maio de 2020): 558. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.558.
Texto completo da fonteLanders, Mark, Rhonda Meredith, Jerry Lee, Yipeng Wang, Byung-In Lee e Joseph Monforte. "Next-generation sequencing mutational analysis of triple-negative breast cancer patients from matched FFPE and fresh frozen samples." Journal of Clinical Oncology 30, n.º 15_suppl (20 de maio de 2012): 1058. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.1058.
Texto completo da fonteAnders, Carey K., Vandana Abramson, Tira Tan e Rebecca Dent. "The Evolution of Triple-Negative Breast Cancer: From Biology to Novel Therapeutics". American Society of Clinical Oncology Educational Book, n.º 36 (maio de 2016): 34–42. http://dx.doi.org/10.1200/edbk_159135.
Texto completo da fonteKhadela, Avinash, Vivek P. Chavda, Shruti Soni, Kaivalya Megha, Aanshi J. Pandya e Lalitkumar Vora. "Anti-Androgenic Therapies Targeting the Luminal Androgen Receptor of a Typical Triple-Negative Breast Cancer". Cancers 15, n.º 1 (30 de dezembro de 2022): 233. http://dx.doi.org/10.3390/cancers15010233.
Texto completo da fonteAndreidesz, Kitti, Balazs Koszegi, Dominika Kovacs, Viola Bagone Vantus, Ferenc Gallyas e Krisztina Kovacs. "Effect of Oxaliplatin, Olaparib and LY294002 in Combination on Triple-Negative Breast Cancer Cells". International Journal of Molecular Sciences 22, n.º 4 (19 de fevereiro de 2021): 2056. http://dx.doi.org/10.3390/ijms22042056.
Texto completo da fonteShiau, Jun-Ping, Cheng-Che Wu, Shu-Jyuan Chang, Mei-Ren Pan, Wangta Liu, Fu Ou-Yang, Fang-Ming Chen, Ming-Feng Hou, Shen-Liang Shih e Chi-Wen Luo. "FAK Regulates VEGFR2 Expression and Promotes Angiogenesis in Triple-Negative Breast Cancer". Biomedicines 9, n.º 12 (29 de novembro de 2021): 1789. http://dx.doi.org/10.3390/biomedicines9121789.
Texto completo da fonteSubhan, Md Abdus, Farzana Parveen, Hassan Shah, Satya Siva Kishan Yalamarty, Janaína Artem Ataide e Valdimir P. Torchilin. "Recent Advances with Precision Medicine Treatment for Breast Cancer including Triple-Negative Sub-Type". Cancers 15, n.º 8 (8 de abril de 2023): 2204. http://dx.doi.org/10.3390/cancers15082204.
Texto completo da fonteJagadish, Nirmala, Sonika Devi, Namita Gupta, Vitusha Suri e Anil Suri. "Knockdown of A-kinase anchor protein 4 inhibits proliferation of triple-negative breast cancer cells in vitro and in vivo". Tumor Biology 42, n.º 4 (abril de 2020): 101042832091447. http://dx.doi.org/10.1177/1010428320914477.
Texto completo da fonteMohammadhosseinpour, Sepideh, Alexx Weaver, Meenakshi Sudhakaran, Linh-Chi Ho, Tra Le, Andrea I. Doseff e Fabricio Medina-Bolivar. "Arachidin-1, a Prenylated Stilbenoid from Peanut, Enhances the Anticancer Effects of Paclitaxel in Triple-Negative Breast Cancer Cells". Cancers 15, n.º 2 (7 de janeiro de 2023): 399. http://dx.doi.org/10.3390/cancers15020399.
Texto completo da fonte